Screener
Nektar Therapeutics NKTR Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
The source filing: Nektar Therapeutics’s 10-K, filed March 13, 2026. Open the filing →
- Filed
- Mar 13, 2026, 12:00 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-104547
FAQ
- What is Nektar Therapeutics's gross profit?
- Nektar Therapeutics (NKTR) reported gross profit of $21.81M in Q4 2025.
- How has Nektar Therapeutics's gross profit changed year-over-year?
- Nektar Therapeutics's gross profit increased by 2.9% year-over-year, from $21.2M to $21.81M.
- What is the long-term trend for Nektar Therapeutics's gross profit?
- Over 4 years (2021 to 2025), Nektar Therapeutics's gross profit has grown at a -8.0% compound annual growth rate (CAGR), from $77.01M to $55.23M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Nektar Therapeutics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude